Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 10, 2026
Credo Technology (CRDO) Declines -32% After Strong Results: What the Pullback Means

Credo Technology (CRDO) Declines -32% After Strong Results: What the Pullback Means

Key Takeaways

  • Credo Technology (CRDO) declined roughly 32% over the 30 days ending in early September 2026, despite delivering record quarterly results.
  • The selloff followed a "beat-and-raise" fiscal Q1 2027 report, as investors focused on narrowing margins and heavy customer concentration rather than surging revenue.
  • GAAP gross margin fell to 64.5%, and second-quarter guidance pointed to further compression, unsettling a stock priced for near-perfect execution.
  • Over the last quarter, the stock has pulled back sharply from its June 2026 52-week high of $308.67 amid elevated volatility across AI-infrastructure names.
  • Analysts remain broadly bullish on the long-term story, but the near-term debate centers on the timing of the optical-business ramp and margin recovery.

Credo Technology (CRDO) at a Glance: Business and Positioning

Credo Technology Group Holding Ltd (NASDAQ: CRDO) is a Santa Clara, California-based provider of high-speed connectivity solutions for data centers and AI infrastructure. Its portfolio spans active electrical cables (AECs), optical digital signal processors (DSPs), silicon photonics photonic integrated circuits (PICs), retimers, and ZeroFlap optical transceivers—a lineup management describes as covering connectivity from "millimeters to kilometers."

Credo's AEC business remains its largest revenue segment, supported by relationships with five hyperscalers—including Microsoft, its first AEC customer—alongside a growing base of "neo-cloud" customers. The company competes for data-center connectivity sockets against larger rivals such as Marvell Technology (MRVL) and Broadcom (AVGO). Investors follow CRDO closely because of its sustained triple-digit revenue growth and its central position in the AI data-center buildout. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CRDO Stock Performance: 30-Day and Quarterly Moves

Over the 30-day period ending in early September 2026, CRDO fell approximately 32%, sliding from a closing price near $247.69 in mid-August to roughly $167.92. The decline was not gradual: the shares dropped about 20% in a single session on September 2, following the company's fiscal first-quarter earnings release, and remained under pressure in the days after.

The longer-term picture shows a similarly sharp retreat. CRDO reached a 52-week high of $308.67 on June 22, 2026, meaning the stock now trades roughly 45% below that peak. The shares had gained about 43.6% year-to-date through the start of September before the post-earnings decline erased a large portion of those gains. The trend over the last quarter has been one of high volatility, punctuated by sector-wide selloffs and a decisive post-earnings repricing.

What Moved CRDO in the Past 30 Days

The primary catalyst was the September 1, 2026 earnings release. Credo reported fiscal Q1 2027 revenue of $479 million, up approximately 115% year over year and above consensus, with non-GAAP earnings per share of $1.20, up about 131%. Management guided second-quarter revenue to $525 million to $535 million, above analyst expectations, and raised its full-year revenue growth outlook to more than 85%.

Despite the strong headline figures, the stock fell sharply. GAAP gross margin declined to 64.5% from 68.2% in the prior quarter, and guidance implied a further drop to a midpoint of 63.9%. Rising operating expenses—including a more than doubling of GAAP operating costs—and higher stock-based compensation added to investor concerns. Customer concentration also drew scrutiny, with the three largest customers accounting for roughly 74% of quarterly revenue. From what I see, this concentration remains a key watchpoint.

Sentiment was further pressured by broader macro conditions. The 10-year Treasury yield rose to about 4.8% in early September, triggering a rotation out of high-valuation semiconductor names, including NVIDIA (NVDA) and AMD (AMD). CRDO's premium valuation left it especially exposed to the reset in rate expectations.

Drivers Behind the Last Quarter's Performance

The quarterly decline reflects a combination of a crowded AI trade unwinding and company-specific execution concerns. After peaking in late June, CRDO pulled back through July as investors de-risked high-multiple semiconductor holdings. The stock recovered into mid-August before the early-September earnings report triggered the largest single-day decline.

The broader narrative over the quarter has been one of exceptional fundamental growth meeting elevated expectations. Credo has now posted seven consecutive quarters of triple-digit year-over-year revenue growth, and its optical business—including optical DSPs, silicon photonics, and ZeroFlap transceivers—is expected to exceed $600 million in revenue in fiscal 2027. Yet the market has increasingly demanded evidence that margin quality and customer diversification keep pace with revenue expansion, which weighed on the shares even as the underlying business continued to grow. I’m watching this closely as the optical ramp progresses.

Key Factors to Watch for CRDO Ahead

Several factors will shape CRDO's stock in the months ahead. The company's fiscal second-quarter earnings report, expected in early December, is the next major catalyst, with investors watching whether GAAP gross margin stabilizes and whether the optical ramp stays on schedule. Progress toward the more than $600 million optical revenue target—split across ZeroFlap Optics, silicon photonics PICs, and optical DSPs—will be closely scrutinized.

Investors should also monitor customer-concentration trends, as management expects three to four customers to remain above 10% of revenue. Macroeconomic conditions, particularly interest-rate movements and AI capital-expenditure trends among hyperscalers, will continue to influence sentiment. Analyst views remain largely bullish, with a Strong Buy consensus, though price targets have diverged—Stifel maintained a $350 target, while BofA lowered its target to $275. The 1.6-terabit DSP ramp, expected to contribute more meaningfully in fiscal 2028, represents a longer-term growth vector. As always, near-term volatility is likely to persist given the stock's elevated beta and concentration risks.

Using Tickeron’s AI Trading Bots for Perspective

In my own process, I sometimes turn to Tickeron’s AI Trading Bots to see how algorithmic strategies have positioned around volatile names like CRDO. The platform hosts a range of bots with different timeframes and approaches, which can provide a useful data-driven layer alongside the fundamentals. It helps highlight real-time signals without replacing core analysis. One thing that stands out is how these tools surface patterns across hundreds of tickers in a structured way.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRDO

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRDO's RSI Indicator is staying in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDO advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRDO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 249 cases where CRDO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRDO as a result. In of 65 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRDO turned negative on August 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRDO moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRDO crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRDO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.561) is normal, around the industry mean (7.415). P/E Ratio (59.127) is within average values for comparable stocks, (156.645). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.657). CRDO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (20.121) is also within normal values, averaging (54.272).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 208.02B. The market cap for tickers in the group ranges from 13.43K to 5.4T. NVDA holds the highest valuation in this group at 5.4T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 46%. SMTC experienced the highest price growth at 22%, while INDI experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 50
SMR Rating: 72
Profit Risk Rating: 74
Seasonality Score: -17 (-100 ... +100)
View a ticker or compare two or three
CRDO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Industry
N/A
Address
c/o Maples Corporate Services
Phone
N/A
Employees
807
Web
https://www.credosemi.com
Interact to see
Advertisement
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.